Max Robotics — Global Service Robot Directory + US Certification

About

Daniel E. Abbott is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for complex abdominal cancers, particularly pancreatic and hepatobiliary malignancies. His most impactful work, a multi-institutional comparison of robotic versus open pancreaticoduodenectomy (284 citations), provided critical early evidence that robotic approaches could achieve comparable perioperative outcomes to open surgery in high-volume centers, helping to legitimize robotic pancreatic surgery. Abbott has also contributed to the cost-effectiveness analysis of minimally invasive distal pancreatectomy and investigated surgical approaches for rectal cancer and pancreatic cystic neoplasms. His research consistently addresses the balance between oncologic efficacy and recovery, exploring underutilized techniques like hand-assisted laparoscopy for pancreatic mucinous cystic neoplasms. Beyond his published work, Abbott’s leadership in multi-center collaborations has shaped modern surgical protocols, and his investigations into rare complications—such as obturator compartment syndrome after robotic prostatectomy—demonstrate his commitment to improving patient safety across the spectrum of minimally invasive surgery.